|
Name |
mollicellin F
|
Molecular Formula | C21H17ClO8 | |
IUPAC Name* |
9-chloro-8,13-dihydroxy-2,2,5,10-tetramethyl-4,11-dioxo-3H-chromeno[6,7-b][1,4]benzodioxepine-7-carbaldehyde
|
|
SMILES |
CC1=C2C(=O)CC(OC2=C(C3=C1OC4=C(C(=C(C(=C4C(=O)O3)C)Cl)O)C=O)O)(C)C
|
|
InChI |
InChI=1S/C21H17ClO8/c1-7-12-17(9(6-23)14(25)13(7)22)28-16-8(2)11-10(24)5-21(3,4)30-18(11)15(26)19(16)29-20(12)27/h6,25-26H,5H2,1-4H3
|
|
InChIKey |
BUWVABSQGVRXOI-UHFFFAOYSA-N
|
|
Synonyms |
mollicellin F; 68455-12-9; CHEBI:68721; 12JN3G4938; 2H,11H-1-Benzopyrano(6,7-b)(1,4)benzodioxepin-7-carboxaldehyde, 9-chloro-3,4-dihydro-8,13-dihydroxy-2,2,5,10-tetramethyl-4,11-dioxo-; Mollicelline F; UNII-12JN3G4938; CHEMBL1080083; DTXSID70218574; 9-Chloro-3,4-dihydro-8,13-dihydroxy-2,2,5,10-tetramethyl-4,11-dioxo-2H,11H-1-benzopyrano(6,7-b)(1,4)benzodioxepin-7-carboxaldehyde; 9-chloro-8,13-dihydroxy-2,2,5,10-tetramethyl-4,11-dioxo-3H-chromeno[6,7-b][1,4]benzodioxepine-7-carbaldehyde; Q27137141; 2H,11H-(1,4)BENZODIOXEPINO(2,3-G)-1-BENZOPYRAN-7-CARBOXALDEHYDE, 9-CHLORO-3,4-DIHYDRO-8,13-DIHYDROXY-2,2,5,10-TETRAMETHYL-4,11-DIOXO-; 6-chloro-5,12-dihydroxy-7,15,15,19-tetramethyl-9,17-dioxo-2,10,14-trioxatetracyclo[9.8.0.0^{3,8}.0^{13,18}]nonadeca-1(19),3(8),4,6,11,13(18)-hexaene-4-carbaldehyde; 9-chloro-8,13-dihydroxy-2,2,5,10-tetramethyl-4,11-dioxo-3,4-dihydro-2H,11H-chromeno[6,7-b][1,4]benzodioxepine-7-carbaldehyde
|
|
CAS | 68455-12-9 | |
PubChem CID | 152841 | |
ChEMBL ID | CHEMBL1080083 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 432.8 | ALogp: | 3.7 |
HBD: | 2 | HBA: | 8 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 119.0 | Aromatic Rings: | 4 |
Heavy Atoms: | 30 | QED Weighted: | 0.374 |
Caco-2 Permeability: | -4.977 | MDCK Permeability: | 0.00002310 |
Pgp-inhibitor: | 0.787 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.495 | 20% Bioavailability (F20%): | 0.004 |
30% Bioavailability (F30%): | 0 |
Blood-Brain-Barrier Penetration (BBB): | 0.01 | Plasma Protein Binding (PPB): | 99.75% |
Volume Distribution (VD): | 0.693 | Fu: | 1.33% |
CYP1A2-inhibitor: | 0.304 | CYP1A2-substrate: | 0.136 |
CYP2C19-inhibitor: | 0.3 | CYP2C19-substrate: | 0.199 |
CYP2C9-inhibitor: | 0.84 | CYP2C9-substrate: | 0.83 |
CYP2D6-inhibitor: | 0.001 | CYP2D6-substrate: | 0.172 |
CYP3A4-inhibitor: | 0.145 | CYP3A4-substrate: | 0.143 |
Clearance (CL): | 0.936 | Half-life (T1/2): | 0.205 |
hERG Blockers: | 0 | Human Hepatotoxicity (H-HT): | 0.046 |
Drug-inuced Liver Injury (DILI): | 0.594 | AMES Toxicity: | 0.065 |
Rat Oral Acute Toxicity: | 0.999 | Maximum Recommended Daily Dose: | 0.902 |
Skin Sensitization: | 0.558 | Carcinogencity: | 0.123 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.899 |
Respiratory Toxicity: | 0.568 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002620 | 0.775 | D06XZW | 0.230 | ||||
ENC002621 | 0.736 | D0WY9N | 0.217 | ||||
ENC000632 | 0.573 | D0FX2Q | 0.210 | ||||
ENC005961 | 0.573 | D0C1SF | 0.208 | ||||
ENC000919 | 0.560 | D0G3DL | 0.207 | ||||
ENC002864 | 0.510 | D0OY9S | 0.206 | ||||
ENC002677 | 0.434 | D01XWG | 0.204 | ||||
ENC005960 | 0.429 | D0R6RC | 0.203 | ||||
ENC000631 | 0.429 | D04ITO | 0.200 | ||||
ENC002865 | 0.417 | D01XDL | 0.195 |